Enhancing precision in colorectal cancer surgery: development of an LGR5-targeting RSPO1 peptide mimetic as a contrast agent for intraoperative fluorescence molecular imaging

References

• Landmann RG, Weiser MR. Surgical management of locally advanced and locally recurrent colon cancer. Clin Colon Rectal Surg. 2005 Aug;18(3):182–189. doi: 10.1055/s-2005-916279
   PubMedGoogle Scholar
• Moran MS, Truong PT. Intraoperative accelerated partial breast irradiation: caution still warranted. Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):496–498. doi: 10.1016/j.ijrobp.2014.01.034
   PubMed Web of Science ®Google Scholar
• Camp ER, McAuliffe PF, Gilroy JS, et al. Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance. J Am Coll Surg. 2005 Dec;201(6):855–861. doi: 10.1016/j.jamcollsurg.2005.06.274
   PubMed Web of Science ®Google Scholar
• Mendenhall WM, Morris CG, Amdur RJ, et al. Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer. 2005 Jun 15;103(12):2544–2550. doi: 10.1002/cncr.21083
   PubMed Web of Science ®Google Scholar
• Jayne DG, Fook S, Loi C, et al. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002 Dec;89(12):1545–1550. doi: 10.1046/j.1365-2168.2002.02274.x
   PubMed Web of Science ®Google Scholar
• Lemmens VE, Klaver YL, Verwaal VJ, et al. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011 Jun 1;128(11):2717–2725. doi: 10.1002/ijc.25596
   PubMed Web of Science ®Google Scholar
• Segelman J, Granath F, Holm T, et al. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012 May;99(5):699–705. doi: 10.1002/bjs.8679
   PubMed Web of Science ®Google Scholar
• Mieog JSD, Achterberg FB, Zlitni A, et al. Fundamentals and developments in fluorescence-guided cancer surgery. Nat Rev Clin Oncol. 2022 Jan;19(1):9–22. doi: 10.1038/s41571-021-00548-3
   PubMed Web of Science ®Google Scholar
• Lauwerends LJ, van Driel P, Baatenburg de Jong RJ, et al. Real-time fluorescence imaging in intraoperative decision making for cancer surgery. Lancet Oncol. 2021 May;22(5):e186–e195. doi: 10.1016/S1470-2045(20)30600-8
   PubMed Web of Science ®Google Scholar
• de Jongh SJ, Voskuil FJ, Schmidt I, et al. C-Met targeted fluorescence molecular endoscopy in Barrett’s esophagus patients and identification of outcome parameters for phase-I studies. Theranostics. 2020;10(12):5357–5367. doi: 10.7150/thno.42224
   PubMed Web of Science ®Google Scholar
• Vries HM, Bekers E, van Oosterom MN, et al. c-MET receptor-targeted fluorescence on the road to image-guided surgery in penile squamous cell carcinoma patients. J Nucl Med. 2022 Jan;63(1):51–56. doi: 10.2967/jnumed.120.261864
   PubMed Web of Science ®Google Scholar
• Zhou J, Joshi BP, Duan X, et al. EGFR overexpressed in colonic neoplasia can be detected on wide-field endoscopic imaging. Clin Transl Gastroenterol. 2015 Jul 16;6(7):e101. doi: 10.1038/ctg.2015.28
   PubMedGoogle Scholar
• de Valk KS, Deken MM, Handgraaf HJM, et al. First-in-human assessment of cRGD-ZW800-1, a zwitterionic, integrin-targeted, near-infrared fluorescent peptide in colon carcinoma. Clin Cancer Res. 2020 Aug 1;26(15):3990–3998. doi: 10.1158/1078-0432.CCR-19-4156
   PubMed Web of Science ®Google Scholar
• Tang Q, Wang J, Frank A, et al. Depth-resolved imaging of colon tumor using optical coherence tomography and fluorescence laminar optical tomography. Biomed Opt Express. 2016 Dec 1;7(12):5218–5232. doi: 10.1364/BOE.7.005218
   PubMed Web of Science ®Google Scholar
• Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA. 1999 May 11;96(10):5522–5527. doi: 10.1073/pnas.96.10.5522
   PubMed Web of Science ®Google Scholar
• Morgan RG, Mortensson E, Williams AC. Targeting LGR5 in colorectal cancer: therapeutic gold or too plastic? Br J Cancer. 2018 May;118(11):1410–1418. doi: 10.1038/s41416-018-0118-6
   PubMed Web of Science ®Google Scholar
• de Sousa e Melo F, Kurtova AV, Harnoss JM, et al. A distinct role for Lgr5(+) stem cells in primary and metastatic colon cancer. Nature. 2017 Mar 29;543(7647):676–680. doi: 10.1038/nature21713
   PubMed Web of Science ®Google Scholar
• Fumagalli A, Oost KC, Kester L, et al. Plasticity of Lgr5-negative cancer cells drives metastasis in colorectal cancer. Cell Stem Cell. 2020 Apr 2;26(4):569–578 e7. doi: 10.1016/j.stem.2020.02.008
   PubMed Web of Science ®Google Scholar
• Ohta Y, Fujii M, Takahashi S, et al. Cell-matrix interface regulates dormancy in human colon cancer stem cells. Nature. 2022 Aug;608(7924):784–794. doi: 10.1038/s41586-022-05043-y
   PubMed Web of Science ®Google Scholar
• Ihemelandu C, Naeem A, Parasido E, et al. Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer. Colorectal Cancer. 2019 Nov 12;8(4):CRC11. doi: 10.2217/crc-2019-0009
   PubMed Web of Science ®Google Scholar
• Jang BG, Kim HS, Chang WY, et al. Expression profile of LGR5 and its prognostic significance in colorectal cancer progression. Am J Pathol. 2018 Oct;188(10):2236–2250. doi: 10.1016/j.ajpath.2018.06.012
   PubMed Web of Science ®Google Scholar
• AbdelMageed M, Ismail HTH, Olsson L, et al. Clinical significance of stem cell biomarkers EpCAM, LGR5 and LGR4 mRNA levels in lymph nodes of colon cancer patients. Int J Mol Sci. 2021 Dec 30;23(1):403. doi: 10.3390/ijms23010403
   PubMed Web of Science ®Google Scholar
• Carmon KS, Gong X, Yi J, et al. LGR5 receptor promotes cell-cell adhesion in stem cells and colon cancer cells via the IQGAP1-Rac1 pathway. J Biol Chem. 2017 Sep 8;292(36):14989–15001. doi: 10.1074/jbc.M117.786798
   PubMed Web of Science ®Google Scholar
• Naeem A, Harish V, Coste S, et al. Regulation of chemosensitivity in human medulloblastoma cells by p53 and the PI3 kinase signaling pathway. Mol Cancer Res. 2022 Jan;20(1):114–126. doi: 10.1158/1541-7786.MCR-21-0277
   PubMed Web of Science ®Google Scholar
• Parasido E, Avetian GS, Naeem A, et al. The sustained induction of c-MYC drives nab-paclitaxel resistance in primary pancreatic ductal carcinoma cells. Mol Cancer Res. 2019 Sep;17(9):1815–1827. doi: 10.1158/1541-7786.MCR-19-0191
   PubMed Web of Science ®Google Scholar
• Kim KA, Wagle M, Tran K, et al. R-Spondin family members regulate the Wnt pathway by a common mechanism. Mol Biol Cell. 2008 Jun;19(6):2588–2596. doi: 10.1091/mbc.e08-02-0187
   PubMed Web of Science ®Google Scholar
• Peng WC, de Lau W, Forneris F, et al. Structure of stem cell growth factor R-spondin 1 in complex with the ectodomain of its receptor LGR5. Cell Rep. 2013 Jun 27;3(6):1885–1892. doi: 10.1016/j.celrep.2013.06.009
   PubMed Web of Science ®Google Scholar
• Huisgen R. 1,3-dipolar cycloadditions. past and future. Angew Chem Int Ed Engl. 1963;2(10):565–598. doi: 10.1002/anie.196305651
   Google Scholar
• van Dam GM, Themelis G, Crane LM, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med. 2011 Sep 18;17(10):1315–1319. doi: 10.1038/nm.2472
   PubMed Web of Science ®Google Scholar
• Tang Q, Nagaya T, Liu Y, et al. 3D mesoscopic fluorescence tomography for imaging micro-distribution of antibody-photon absorber conjugates during near infrared photoimmunotherapy in vivo. J Control Release. 2018 Jun 10;279:171–180. doi: 10.1016/j.jconrel.2018.04.027
   PubMed Web of Science ®Google Scholar
• Nagengast WB, Hartmans E, Garcia-Allende PB, et al. Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor a. Gut. 2019 Jan;68(1):7–10. doi: 10.1136/gutjnl-2017-314953
   PubMed Web of Science ®Google Scholar
• Lorenser D, Quirk BC, Auger M, et al. Dual-modality needle probe for combined fluorescence imaging and three-dimensional optical coherence tomography. Opt Lett. 2013 Feb 1;38(3):266–268. doi: 10.1364/OL.38.000266
   PubMed Web of Science ®Google Scholar
• Zhang Z, Broderick C, Nishimoto M, et al. Tissue-targeted R-spondin mimetics for liver regeneration. Sci Rep. 2020 Aug 18;10(1):13951. doi: 10.1038/s41598-020-70912-3
   PubMed Web of Science ®Google Scholar
• Kwak MH, Yang SM, Yun SK, et al. Identification and validation of LGR5-binding peptide for molecular imaging of gastric cancer. Biochem Biophys Res Commun. 2021 Nov 26;580:93–99. doi: 10.1016/j.bbrc.2021.09.073
   PubMed Web of Science ®Google Scholar
• Haegebarth A, Clevers H. Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol. 2009 Mar;174(3):715–721. doi: 10.2353/ajpath.2009.080758
   PubMed Web of Science ®Google Scholar
• Zhao Y, Feng F, Zhou YN. Stem cells in gastric cancer. World J Gastroenterol. 2015 Jan 7;21(1):112–123. doi: 10.3748/wjg.v21.i1.112
   PubMed Web of Science ®Google Scholar
• Katoh M. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review). Int J Oncol. 2017 Nov;51(5):1357–1369. doi: 10.3892/ijo.2017.4129
   PubMed Web of Science ®Google Scholar
• Lee S, Jun J, Kim WJ, et al. WNT signaling driven by R-spondin 1 and LGR6 in high-grade serous ovarian cancer. Anticancer Res. 2020 Nov;40(11):6017–6028. doi: 10.21873/anticanres.14623
   PubMed Web of Science ®Google Scholar
• Kim H, Lee DH, Park E, et al. Differential epithelial and stromal LGR5 expression in ovarian carcinogenesis. Sci Rep. 2022 Jul 1;12(1):11200. doi: 10.1038/s41598-022-15234-2
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang X, Li WM, et al. Prognostic value of LGR5 in colorectal cancer: a meta-analysis. PLOS ONE. 2014;9(9):e107013. doi: 10.1371/journal.pone.0107013
   PubMed Web of Science ®Google Scholar
• Jiang Y, Li W, He X, et al. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis. BMC Cancer. 2016 Jan 12;16(1):12. doi: 10.1186/s12885-015-1986-2
   PubMedGoogle Scholar
• Sato K, Uehara T, Iwaya M, et al. Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma. Ann Diagn Pathol. 2020 Oct;48:151587. doi: 10.1016/j.anndiagpath.2020.151587
   PubMed Web of Science ®Google Scholar
• Posey TA, Jacob J, Parkhurst A, et al. Loss of LGR5 through therapy-induced downregulation or gene ablation is associated with resistance and enhanced MET-STAT3 signaling in colorectal cancer cells. Mol Cancer Ther. 2023 May 4;22(5):667–678. doi: 10.1158/1535-7163.MCT-22-0415
   PubMed Web of Science ®Google Scholar
• Usama SM, Thapaliya ER, Luciano MP, et al. Not so innocent: Impact of fluorophore chemistry on the in vivo properties of bioconjugates. Curr Opin Chem Biol. 2021 Aug;63:38–45. doi: 10.1016/j.cbpa.2021.01.009
   PubMed Web of Science ®Google Scholar
• Hernandez Vargas S, AghaAmiri S, Ghosh SC, et al. High-contrast detection of somatostatin receptor subtype-2 for fluorescence-guided surgery. Mol Pharm. 2022 Nov 7;19(11):4241–4253. doi: 10.1021/acs.molpharmaceut.2c00583
   PubMedGoogle Scholar
• Usama SM, Marker SC, Li DH, et al. Method to diversify cyanine chromophore functionality enables improved biomolecule tracking and intracellular imaging. J Am Chem Soc. 2023 Jul 12;145(27):14647–14659. doi: 10.1021/jacs.3c01765
   PubMed Web of Science ®Google Scholar